OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
EBS Emergent BioSolutions
- 4.870
- +0.010+0.21%
Trading Apr 1 09:30 ET
264.62MMarket Cap-1.35P/E (TTM)
4.870High4.870Low42.19KVolume4.870Open4.860Pre Close205.48KTurnover0.08%Turnover RatioLossP/E (Static)54.34MShares15.10052wk High0.55P/B257.44MFloat Cap1.82052wk Low--Dividend TTM52.86MShs Float137.610Historical High--Div YieldTTM0.00%Amplitude1.420Historical Low4.870Avg Price1Lot Size
About Emergent BioSolutions Company
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.
Company Profile
SymbolEBS
Company NameEmergent BioSolutions
Listing DateOct 2, 2009
Issue Price12.50
Founded1998
CEOMr. Joseph C. Papa
MarketNYSE
Employees900
Fiscal Year Ends12-31
Address300 Professional Drive,Suite 400
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20879
Phone1-240-631-3200
Company Executives
- Name
- Position
- Salary
- Joseph C. Papa
- Director, President and Chief Executive Officer
- 5.86M
- Simon C. Lowry, M.D.
- Chief Medical Officer and Head of Research and Development
- --
- Richard S. Lindahl
- Principal Accounting Officer, Executive Vice President, Chief Financial Officer and Treasurer
- 2.31M
- Jessica Perl
- Senior Vice President, General Counsel and Corporate Secretary
- --
- Coleen Glessner
- Executive Vice President, Quality and Ethics and Compliance
- 2.05M
- William Hartzel
- Senior Vice President, Manufacturing and Bioservice
- --
- Paul Williams
- Senior Vice President, Products Business
- 1.68M
- Dr. Zsolt Harsanyi,PhD
- Chairman of the Board
- 420.00K
- Sujata Dayal
- Independent Director
- 275.00K
- Ronald B. Richard
- Independent Director
- 275.00K
- Neal F. Fowler
- Independent Director
- 270.00K
- Marvin L. White
- Independent Director
- 290.00K
- Keith A. Katkin
- Independent Director
- 285.00K
- Donald W. DeGolyer
- Independent Director
- 265.00K
- Dr. Louis W. Sullivan, M.D.
- Independent Director
- 275.00K
- Dr. Kathryn C. Zoon, PhD
- Independent Director
- 285.00K
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings